CVE:NES

Newstrike Capital Stock Forecast, Price & News

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume400 shs

Average Volume13,422 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive NES News and Ratings via Email

Sign-up to receive the latest news and ratings for Newstrike Capital and its competitors with MarketBeat's FREE daily newsletter.

About Newstrike Capital

Newstrike Capital Inc is a Canada-based exploration stage company. The Company is engaged in the business of acquiring, exploring, evaluating and developing mineral property concessions in Mexico. The Company's projects are: Ana Paula ,Aurea Norte, Aurea Sur, Oaxaca. The Ana Paula Project is located in the Guerrero Gold Belt in the State of Guerrero, Mexico. The Aurea Norte Project lies on the untested northwest extension. The project covers the northwest extension of the Guerrero Gold Belt and is contiguous with the Aurea Sur Project to the south. The Aurea Sur lies to the west of the known Guerrero Gold Belt. The Oaxaca is an early-stage project is focused on mid-tertiary polymetalic epithermal-style mineralization close to the Taviche, San Jose, Ejutla, and Lachigalla Mining Districts.

Newstrike Brands Ltd. Wt
October 18, 2020 | wsj.com

2 Canadian Marijuana Stocks to Avoid in 2020
September 15, 2020 | ca.finance.yahoo.com

Marijuana Investors: 2 Canadian Pot Stocks to Avoid In 2020
August 28, 2020 | ca.finance.yahoo.com

The Only 3 Pot Stocks Whose Earnings Estimates Are Rising
July 15, 2020 | www.nasdaq.com

AMENDED AND RESTATED NEWS RELEASE - Aurora Cannabis Submits Proposal to CanniMed Therapeutics Board Aurora Cannabis Executes Lo
May 22, 2020 | www.bloomberg.com

HEXO Stock Price to Fall If Management Misses Tight Deadline
March 31, 2020 | ca.finance.yahoo.com

The 3 Most Important Numbers in HEXO's Horrible Q2 Results
March 30, 2020 | www.fool.com

Weekly Cannabis Report: LPs Rethinking Their M&A Strategy
February 25, 2020 | seekingalpha.com

Are Pot Stocks Like Aurora Cannabis (TSX:ACB) and Hexo (TSX:HEXO) Running Out of Cash?
February 19, 2020 | ca.finance.yahoo.com

AMENDED AND RESTATED NEWS RELEASE - Aurora Cannabis Announces Intention to Launch Takeover Bid for CanniMed Therapeutics Inc.
February 14, 2020 | www.bloomberg.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange CVE
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolCVE:NES
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.newstrikecapital.com
Phone+1-604-8066110
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.56 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Newstrike Capital.

2.8 Community Rank

Outperform Votes
Newstrike Capital has received 58 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Newstrike Capital has received 44 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Newstrike Capital has received 56.86% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Newstrike Capital and other stocks. Vote “Outperform” if you believe NES will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NES will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Newstrike Capital does not currently pay a dividend.
Dividend Growth
Newstrike Capital does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Newstrike Capital insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Newstrike Capital (CVE:NES) Frequently Asked Questions

What stocks does MarketBeat like better than Newstrike Capital?

Wall Street analysts have given Newstrike Capital a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Newstrike Capital wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What other stocks do shareholders of Newstrike Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Newstrike Capital investors own include Advanced Micro Devices (AMD), Curaleaf (CURLF), Emerald Health Therapeutics (EMHTF), KKR Real Estate Finance Trust (KREF), Manulife Financial (MFC), Trimble (TRMB), Advent Convertible and Income Fund (AVK), Altisource Portfolio Solutions (ASPS), ARMOUR Residential REIT (ARR) and Apollo Commercial Real Estate Finance (ARI).

What is Newstrike Capital's stock symbol?

Newstrike Capital trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NES."

How do I buy shares of Newstrike Capital?

Shares of NES and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Newstrike Capital's official website?

The official website for Newstrike Capital is www.newstrikecapital.com.

Where are Newstrike Capital's headquarters?

Newstrike Capital is headquartered at Suite 2000, 1066 West Hastings Street, VANCOUVER, BC V6E 3X2, Canada.

How can I contact Newstrike Capital?

Newstrike Capital's mailing address is Suite 2000, 1066 West Hastings Street, VANCOUVER, BC V6E 3X2, Canada. The company can be reached via phone at +1-604-8066110.

This page was last updated on 6/14/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.